FDA Approval for New Cardiac Devices in Advanced Diagnostic Imaging

Medtronic is a large medical technology, services and solutions company and manufactures a range of devices for interventional, and surgical treatment of cardiac arrhythmias, and cardiovascular disease.

Yair Safriel, MD, neuroradiologist, CMO, Pharmascan Clinical Trials, and University of South Florida, said, "While 1.5T scanners still comprise the majority of installations, 3T scanners are expected to comprise more than half of new units - with some centers having only 3T scanners - since they offer faster scans and higher resolution images. Approval for MRI conditional scanning at both 1.5 and 3T allows patients to have improved access to MRI at a time and place most appropriate for their care. And with 3T scanning, physicians and radiologists gain a clearer look into soft tissues, particularly critical when diagnosing serious conditions, often involving the brain and spine."

Related Links:
Medtronic